Skip to content
The Policy VaultThe Policy Vault

Welireg (belzutifan tablets - Merck) — Cigna

Pheochromocytoma or Paraganglioma

Initial criteria

  • Patient is age ≥ 12 years; AND
  • Patient has locally advanced, unresectable, or metastatic disease

Approval duration

1 year